Sofinnova Investments, Inc. Orchard Therapeutics PLC Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$5.65 - $15.71 $1.6 Million - $4.45 Million	-283,406 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$11.88 - $16.72 $974,908 - $1.37 Million	-82,063 Reduced 22.45%	283,406 $3.37 Million
Q2 2019 Aug 13, 2019	BUY	$13.2 - $20.63 $1.18 Million - $1.84 Million	89,386 Added 32.38%	365,469 $5.11 Million
Q1 2019 May 15, 2019	BUY	$12.01 - $19.49 $642,114 - $1.04 Million	53,465 Added 24.02%	276,083 $4.94 Million
Q4 2018 Feb 14, 2019	BUY	$12.4 - $18.7 $2.76 Million - $4.16 Million	222,618 New	222,618 $3.5 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.